Predictive value of GATA3 and Ki-67 expression in biopsy and transurethral resection specimens in patients with urothelial carcinoma of the urinary bladder

被引:1
作者
Sunjevic, Milena [1 ,2 ]
Bogdanovic, Jovo [3 ,4 ]
Trivunic-Dajko, Sandra [1 ,2 ]
机构
[1] Univ Novi Sad, Dept Pathol, Fac Med, Novi Sad, Serbia
[2] Univ Clin Ctr Vojvodina, Ctr Pathol & Histol, Novi Sad, Serbia
[3] Univ Novi Sad, Dept Surg, Fac Med, Novi Sad, Serbia
[4] Univ Clin Ctr Vojvodina, Urol Clin, Novi Sad, Serbia
关键词
urothelial carcinoma; biopsy; transurethral resection; GATA3; Ki-67; CANCER; UTILITY; P53;
D O I
10.2298/SARH220312072S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction/Objective Urothelial carcinoma is the most commonly diagnosed malignancy of urinary bladder in clinical and pathohistological practice where various prognostic factors play a significant role. One of the most important pathohistological prognostic factors is the intensity of immunohistochemical staining. Among various immunohistochemical markers that have been proven to influence disease progression and the patient's survival, role of Ki-67 and GATA3 in prediction of disease prognosis has not been completely clarified yet. The aim of this study was to determine the predictive value of GATA3 and Ki-67 mutual expression in urothelial carcinoma. Methods Eighty patients were included in this study, out of which four groups were formed based on the pathological stage of urothelial carcinoma. After using preferred antibodies, their staining intensity was analyzed semiquantitatively. Results Results showed that there was statistically significant correlation between the type of urothelial carcinoma, the pathological stage, and invasiveness and different grades of GATA3 expression, as well as statistically significant correlation between the type of urothelial carcinoma and the pathological stage and different grades of Ki-67 expression. The regression model showed low value of GATA3 and Ki-67 mutual expression. There was also statistical significance regarding the pathological stage and invasiveness of the tumor in survival analysis. Conclusion Predictive value of GATA3 and Ki-67 mutual expression resulted as low from this study, but to our knowledge this was the first study to examine their predictive capability on biopsy and transurethral resection specimens.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 26 条
  • [1] Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma
    Agarwal, Harshita
    Babu, Suresh
    Rana, Chanchal
    Kumar, Madhu
    Singhai, Atin
    Shankhwar, Shiv Narayan
    Singh, Vishwajeet
    Sinha, Rahul Janak
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2019, 62 (02) : 244 - 250
  • [2] The applicability and utility of immunohistochemical biomarkers in bladder pathology
    Akgul, Mahmut
    MacLennan, Gregory T.
    Cheng, Liang
    [J]. HUMAN PATHOLOGY, 2020, 98 : 32 - 55
  • [3] Ali Mohamed S, 2019, INT J CHIN MED, V3, P1, DOI [10.11648/j.ijcm.20190301.11, DOI 10.11648/J.IJCM.20190301.11]
  • [4] A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases
    Bontoux, Christophe
    Rialland, Thomas
    Cussenot, Olivier
    Comperat, Eva
    [J]. VIRCHOWS ARCHIV, 2021, 478 (04) : 637 - 645
  • [5] Cancer statistics for adults aged 85 years and older, 2019
    DeSantis, Carol E.
    Miller, Kimberly D.
    Dale, William
    Mohile, Supriya G.
    Cohen, Harvey J.
    Leach, Corinne R.
    Sauer, Ann Goding
    Lemal, Ahmedin
    Siegel, Rebecca L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (06) : 452 - 467
  • [6] Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma
    El-Gendi, Saba
    Abu-Sheasha, Ghada
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (02) : 309 - 322
  • [7] Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer
    Fernandez, Mario I.
    Brausi, Maurizio
    Clark, Peter E.
    Cookson, Michael S.
    Grossman, H. Barton
    Khochikar, Makarand
    Kiemeney, Lambertus A.
    Malavaud, Bernard
    Sanchez-Salas, Rafael
    Soloway, Mark S.
    Svatek, Robert S.
    Vikram, Raghunandan
    Vrieling, Alina
    Kamat, Ashish M.
    [J]. WORLD JOURNAL OF UROLOGY, 2019, 37 (01) : 3 - 13
  • [8] Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review
    Fonteyne, Valerie
    Ost, Piet
    Bellmunt, Joaquim
    Droz, Jean Pierre
    Mongiat-Artus, Pierre
    Inman, Brant
    Paillaud, Elena
    Saad, Fred
    Ploussard, Guillaume
    [J]. EUROPEAN UROLOGY, 2018, 73 (01) : 40 - 50
  • [9] Long-term Outcomes from Re-resection for High-risk Non-muscle-invasive Bladder Cancer: A Potential to Rationalize Use
    Gordon, Patrick C.
    Thomas, Francis
    Noon, Aidan P.
    Rosario, Derek J.
    Catto, James W. F.
    [J]. EUROPEAN UROLOGY FOCUS, 2019, 5 (04): : 650 - 657
  • [10] GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator
    Inoue, Satoshi
    Mizushima, Taichi
    Fujita, Kazutoshi
    Meliti, Abdelrazak
    Ide, Hiroki
    Yamaguchi, Seiji
    Fushimi, Hiroaki
    Netto, George J.
    Nonomura, Norio
    Miyamoto, Hiroshi
    [J]. HUMAN PATHOLOGY, 2017, 64 : 83 - 90